Barr makes new try for FDA approval of Plan B OTC sales

Barr Pharmaceuticals is making a second attempt at getting the FDA to approve its morning-after Plan B contraceptive drug for over-the-counter sales by limiting such sales to women at least 16 years old. The plan submitted to the agency is an attempt to overturn the agency's May ruling against OTC sales of Plan B.

View Full Article in:

Newsday (Long Island, N.Y.) (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ